Brokerages Set Generation Bio Co. (NASDAQ:GBIO) Target Price at $12.31

Generation Bio Co. (NASDAQ:GBIO – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the six brokerages that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price objective among […]

Related Keywords

Massachusetts ,United States ,William Blair ,Nasdaq ,Cheyne Capital Management United Kingdom ,Td Asset Management Inc ,Health Sciences ,Generation Bio Company Profile ,Connor Clark Lunn Investment Management Ltd ,Needham Company ,Massachusetts Financial Services Co ,Generation Bio Co ,Generation Bio ,Get Rating ,Financial Services ,Capital Management United Kingdom ,Connor Clark ,Lunn Investment Management ,Generation Bio Daily ,